Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$13.99 USD
-0.28 (-1.96%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $14.00 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SBRA 13.99 -0.28(-1.96%)
Will SBRA be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for SBRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SBRA
Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics
Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS
SBRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates
Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Other News for SBRA
What's Driving Medical Properties Trust Inc's Surprising 27% Stock Rally?
Picking A Winner In Healthcare REITs
Bag This Bargain 8.3% Yield Dividend Stock Even Cheaper Than Director Cusack Did
Sabra Health Care REIT Named Top Dividend Stock With Insider Buying and 8.32% Yield (SBRA)
Rally Gets Reality Check